S

Surgical Science Sweden AB
STO:SUS

Watchlist Manager
Surgical Science Sweden AB
STO:SUS
Watchlist
Price: 129.4 SEK 0.7%
Market Cap: 6.6B SEK
Have any thoughts about
Surgical Science Sweden AB?
Write Note

Surgical Science Sweden AB
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Surgical Science Sweden AB
Cash & Cash Equivalents Peer Comparison

Comparables:
EKTA B
CEVI
GETI B
ARJO B
S
STIL

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
S
Surgical Science Sweden AB
STO:SUS
Cash & Cash Equivalents
kr667.1m
CAGR 3-Years
36%
CAGR 5-Years
81%
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Cash & Cash Equivalents
kr2.8B
CAGR 3-Years
-8%
CAGR 5-Years
3%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Cash & Cash Equivalents
kr122.3m
CAGR 3-Years
10%
CAGR 5-Years
-8%
CAGR 10-Years
10%
Getinge AB
STO:GETI B
Cash & Cash Equivalents
kr2.7B
CAGR 3-Years
-23%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Cash & Cash Equivalents
kr923m
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Cash & Cash Equivalents
kr90.9m
CAGR 3-Years
77%
CAGR 5-Years
23%
CAGR 10-Years
52%

See Also

What is Surgical Science Sweden AB's Cash & Cash Equivalents?
Cash & Cash Equivalents
667.1m SEK

Based on the financial report for Jun 30, 2024, Surgical Science Sweden AB's Cash & Cash Equivalents amounts to 667.1m SEK.

What is Surgical Science Sweden AB's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
81%

Over the last year, the Cash & Cash Equivalents growth was 16%. The average annual Cash & Cash Equivalents growth rates for Surgical Science Sweden AB have been 36% over the past three years , 81% over the past five years .

Back to Top